Aberdeen Group plc Increases Stake in Cardinal Health, Inc. $CAH

Key Points

• Aberdeen Group plc increased its stake in Cardinal Health by 14.2% during the second quarter, owning approximately 0.10% of the company worth $38.5 million by the end of the quarter.
• Wall Street analysts have observed a moderate outlook for Cardinal Health, with a consensus target price of $166.00 and twelve analysts rating it as a “Buy.”
• Insider transactions revealed significant sales, as CEO Jason M. Hollar sold over 107,000 shares, decreasing his ownership by 31.35%.

Aberdeen Group plc boosted its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 14.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 229,460 shares of the company's stock after purchasing an additional 28,520 shares during the quarter. Aberdeen Group plc owned about 0.10% of Cardinal Health worth $38,549,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health during the first quarter valued at approximately $26,000. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after buying an additional 14,034 shares during the last quarter. GW&K Investment Management LLC lifted its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after purchasing an additional 144 shares during the period. Garde Capital Inc. bought a new position in Cardinal Health during the first quarter valued at approximately $52,000. Finally, Zions Bancorporation National Association UT bought a new position in Cardinal Health during the first quarter valued at approximately $52,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CAH shares. Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Evercore ISI dropped their price target on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reissued a "buy (b)" rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Finally, UBS Group reissued a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $166.00.

Insider Activity at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company's stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 107,705 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer directly owned 235,901 shares in the company, valued at $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last ninety days. Corporate insiders own 0.12% of the company's stock.

Cardinal Health Price Performance

Cardinal Health stock opened at $156.86 on Monday. The business has a fifty day moving average price of $152.09 and a 200-day moving average price of $151.31. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The stock has a market capitalization of $37.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same period in the prior year, the company posted $1.84 EPS. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.